/
/
/

Krsnaa Diagnostics Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--17%8%
--18%31%
--7%-5%-35%
9%9%9%11%

Peer Comparison

Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
MEDANTA
NH
KIMS
LALPATHLAB
VIJAYA
KRSNAA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,911₹130273 Cr62.3540.39207.67₹1942 Cr
1,046.9₹102446 Cr70.323.3119.84₹1442 Cr
742.3₹100021 Cr112.091.9611.95₹892 Cr
879.3₹67267 Cr64.193.5320.1₹1042 Cr
769.3₹66295 Cr208.030.316.76₹388 Cr
1,507.6₹40209 Cr72.35.9129.85₹556 Cr
1,879.1₹39270 Cr48.1210.1465.36₹806 Cr
801.9₹33529 Cr164.121.0412.74₹241 Cr
1,962.8₹32271 Cr59.5510.1142.51₹505 Cr
1,528.1₹16149 Cr86.135.1627.53₹173 Cr
552₹1815 Cr18.635.159.88₹101 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
₹236 Cr₹193 Cr₹181 Cr₹206 Cr₹193 Cr₹186 Cr₹175 Cr₹186 Cr₹170 Cr₹166 Cr₹158 Cr₹155 Cr₹140 Cr₹133 Cr₹118 Cr₹123 Cr₹113 Cr₹108 Cr₹106 Cr₹108 Cr₹132 Cr
₹7 Cr₹31 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹9 Cr₹5 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr
₹243 Cr₹224 Cr₹185 Cr₹210 Cr₹197 Cr₹190 Cr₹184 Cr₹191 Cr₹178 Cr₹171 Cr₹162 Cr₹160 Cr₹144 Cr₹139 Cr₹123 Cr₹127 Cr₹117 Cr₹112 Cr₹111 Cr₹111 Cr₹136 Cr
₹206 Cr₹160 Cr₹157 Cr₹170 Cr₹163 Cr₹155 Cr₹152 Cr₹159 Cr₹149 Cr₹141 Cr₹142 Cr₹143 Cr₹124 Cr₹113 Cr₹103 Cr₹105 Cr₹97 Cr₹91 Cr₹87 Cr₹87 Cr₹101 Cr
₹65 Cr₹86 Cr₹50 Cr₹63 Cr₹55 Cr₹57 Cr₹54 Cr₹54 Cr₹50 Cr₹48 Cr₹41 Cr₹36 Cr₹36 Cr₹40 Cr₹34 Cr₹35 Cr₹32 Cr₹32 Cr₹34 Cr₹35 Cr₹45 Cr
₹15 Cr₹12 Cr₹8 Cr₹8 Cr₹6 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹7 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹8 Cr₹6 Cr
₹22 Cr₹52 Cr₹20 Cr₹32 Cr₹27 Cr₹29 Cr₹25 Cr₹25 Cr₹23 Cr₹23 Cr₹16 Cr₹13 Cr₹18 Cr₹24 Cr₹18 Cr₹20 Cr₹19 Cr₹20 Cr₹21 Cr₹17 Cr₹29 Cr
₹17 Cr₹42 Cr₹15 Cr₹24 Cr₹21 Cr₹21 Cr₹19 Cr₹20 Cr₹18 Cr₹19 Cr₹13 Cr₹10 Cr₹15 Cr₹19 Cr₹14 Cr₹15 Cr₹14 Cr₹18 Cr₹16 Cr₹13 Cr₹22 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
—————
₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr
₹8 Cr₹6 Cr₹2 Cr₹3 Cr₹2 Cr
₹956 Cr₹860 Cr₹791 Cr₹720 Cr₹667 Cr
₹956 Cr₹860 Cr₹791 Cr₹720 Cr₹667 Cr
₹980 Cr₹883 Cr₹810 Cr₹739 Cr₹684 Cr
₹437 Cr₹19 Cr₹6 Cr₹11 Cr₹20 Cr
₹25 Cr₹19 Cr₹15 Cr₹11 Cr₹7 Cr
₹98 Cr₹49 Cr₹57 Cr₹47 Cr₹43 Cr
₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹32 L
₹563 Cr₹90 Cr₹79 Cr₹71 Cr₹70 Cr
—————
₹63 Cr₹97 Cr₹82 Cr₹62 Cr₹77 Cr
₹189 Cr₹60 Cr₹99 Cr₹35 Cr₹42 Cr
₹11 Cr₹139 Cr₹96 Cr₹0₹0
₹12 Cr₹9 Cr₹4 Cr₹2 Cr₹2 Cr
₹275 Cr₹305 Cr₹281 Cr₹99 Cr₹121 Cr
₹1819 Cr₹1278 Cr₹1170 Cr₹909 Cr₹875 Cr
₹66 Cr₹55 Cr₹23 Cr₹4 Cr₹4 Cr
₹491 Cr₹166 Cr₹107 Cr₹17 Cr₹26 Cr
—————
₹1042 Cr₹971 Cr₹874 Cr₹627 Cr₹491 Cr
₹386 Cr₹300 Cr₹226 Cr₹156 Cr₹106 Cr
₹656 Cr₹670 Cr₹647 Cr₹471 Cr₹386 Cr
₹208 Cr₹3 Cr₹10 Cr₹25 Cr₹28 Cr
₹57 Cr₹32 Cr₹29 L₹29 L₹29 L
₹57 Cr₹32 Cr₹29 L₹29 L₹29 L
₹124 Cr₹45 Cr₹62 Cr₹26 Cr₹18 Cr
₹35 Cr₹114 Cr₹29 Cr₹163 Cr₹109 Cr
₹1080 Cr₹864 Cr₹749 Cr₹686 Cr₹541 Cr
—————
₹27 Cr₹29 Cr₹36 Cr₹25 Cr₹9 Cr
₹296 Cr₹278 Cr₹176 Cr₹73 Cr₹58 Cr
₹361 Cr₹68 Cr₹175 Cr₹109 Cr₹242 Cr
₹24 Cr₹30 Cr₹24 Cr₹10 Cr₹8 Cr
₹31 Cr₹9 Cr₹10 Cr₹6 Cr₹17 Cr
₹738 Cr₹414 Cr₹421 Cr₹223 Cr₹334 Cr
₹463 Cr₹109 Cr₹140 Cr₹124 Cr₹213 Cr
₹1819 Cr₹1278 Cr₹1170 Cr₹909 Cr₹875 Cr
₹300₹271₹250₹234₹217
₹300₹271₹250₹234₹217

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
₹130 Cr₹103 Cr₹70 Cr₹80 Cr₹87 Cr
₹87 Cr₹98 Cr₹70 Cr₹45 Cr₹49 Cr
-₹47 Cr-₹93 Cr-₹97 Cr-₹36 Cr-₹66 L
₹171 Cr₹107 Cr₹43 Cr₹89 Cr₹135 Cr
₹143 Cr₹87 Cr₹24 Cr₹76 Cr₹128 Cr
-₹396 Cr-₹100 Cr-₹129 Cr-₹109 Cr-₹241 Cr
₹279 Cr₹14 Cr₹84 Cr-₹33 Cr₹176 Cr
₹26 Cr₹1 Cr-₹20 Cr-₹66 Cr₹64 Cr
₹4 Cr₹2 Cr₹23 Cr₹88 Cr₹25 Cr
₹30 Cr₹4 Cr₹2 Cr₹23 Cr₹88 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)565.00
Volume (₹)40,975.00
High (₹)565.00
Upper Circuit672.05
Low (₹)549.30
Lower Circuit448.05
Prev Close560.05
52W High (₹)894.40
Price552.00
52W Low (₹)515.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1815.27 Cr
Div. Yield (%)0.36
PE Ratio18.63
Debt to Equity0.50
Price to Book1.74
Book Value299.69
EPS (TTM)30.04
Face Value5.00
ROE (%)10.97

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
MEDANTANSE
NHNSE
KIMSNSE
LALPATHLABNSE
VIJAYANSE
KRSNAANSE
LTP
1W Low
1W High
Market cap (₹)
8911-33.5 (-0.37%)
8822.50
9070.50
1,30,273Cr
1046.9-2.4 (-0.23%)
1029
1072.60
1,02,446Cr
742.3+3.35 (0.45%)
733.20
769.75
1,00,021Cr
879.3-6.7 (-0.76%)
879.30
908.80
67,267Cr
769.3+14.25 (1.89%)
734.35
780
66,295Cr
1507.6+8.2 (0.55%)
1467.60
1527
40,209Cr
1879.1-49.4 (-2.56%)
1870
1932.90
39,270Cr
801.9-7.95 (-0.98%)
785
818.95
33,529Cr
1962.8+65.9 (3.47%)
1890
1976.20
32,271Cr
1528.1-30.8 (-1.98%)
1505.70
1593.60
16,149Cr
552+10.85 (2.00%)
536
573.90
1,815Cr

Krsnaa Diagnostics Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹65.22Cr; with other income of ₹7.24Cr, profit before interest and tax came to ₹37.27Cr. Interest expense was ₹14.83Cr; PBT before exceptional items stood at ₹22.43Cr. Basis: consolidated annual results.

Krsnaa Diagnostics Ltd Quaterly Results Key Takeaways

Krsnaa Diagnostics Ltd reported ₹235.53Cr total income from operations in Jun 2026, softer than ₹192.6Cr in Mar 2026 but higher than ₹192.98Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹65.22Cr; with other income of ₹7.24Cr, profit before interest and tax came to ₹37.27Cr. Interest expense was ₹14.83Cr, taking profit before tax to ₹22.43Cr. After tax of ₹5.88Cr, profit after tax stood at ₹16.55Cr (vs ₹41.72Cr in Mar 2026 and ₹20.51Cr in Jun 2025).